JPH0148245B2 - - Google Patents

Info

Publication number
JPH0148245B2
JPH0148245B2 JP56104350A JP10435081A JPH0148245B2 JP H0148245 B2 JPH0148245 B2 JP H0148245B2 JP 56104350 A JP56104350 A JP 56104350A JP 10435081 A JP10435081 A JP 10435081A JP H0148245 B2 JPH0148245 B2 JP H0148245B2
Authority
JP
Japan
Prior art keywords
furosemide
penbutrol
piretanide
salts
diuretics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56104350A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5756426A (en
Inventor
Mushauetsuku Rooman
Fuyuruberuto Uerunaa
Jitsukumyuraa Arufuretsuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of JPS5756426A publication Critical patent/JPS5756426A/ja
Publication of JPH0148245B2 publication Critical patent/JPH0148245B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP56104350A 1980-07-04 1981-07-03 Novel salt and manufacture Granted JPS5756426A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803025367 DE3025367A1 (de) 1980-07-04 1980-07-04 Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Publications (2)

Publication Number Publication Date
JPS5756426A JPS5756426A (en) 1982-04-05
JPH0148245B2 true JPH0148245B2 (enExample) 1989-10-18

Family

ID=6106415

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56104350A Granted JPS5756426A (en) 1980-07-04 1981-07-03 Novel salt and manufacture

Country Status (8)

Country Link
US (1) US4564625A (enExample)
EP (1) EP0043548B1 (enExample)
JP (1) JPS5756426A (enExample)
AT (1) ATE8627T1 (enExample)
AU (1) AU538612B2 (enExample)
CA (1) CA1161449A (enExample)
DE (2) DE3025367A1 (enExample)
ZA (1) ZA814523B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
US5256687A (en) * 1985-09-09 1993-10-26 Hoechst Aktiengesellschaft Pharmaceutical composition for the treatment of high blood pressure
DE3617824A1 (de) * 1986-05-27 1987-12-03 Hoechst Ag Zusammensetzung fuer transdermale therapeutische systeme von schleifendiuretika
US4698361A (en) * 1986-05-28 1987-10-06 Schiena Michele G Di Tris-chydroxymethyl) aminomethane salt of 4-chloro-N-furfuryl-5-sulfamoyl anthranilic acid and diuretic compositions containing the same
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839321A (en) * 1966-07-21 1974-10-01 Smithkline Corp 5-sulfamoyl-n-(2-substituted-ethyl) anthranilic acids
IL39625A0 (en) * 1971-06-15 1972-11-28 Ciba Geigy Ag New pharmaceutical preparations for the treatment of hypertonia,containing a diuretic and a beta-receptor blocking agent
US4139633A (en) * 1971-06-15 1979-02-13 Ciba-Geigy Corporation Pharmaceutical preparations for the treatment of hypertonia
AT356095B (de) * 1975-04-24 1980-04-10 Hoechst Ag Verfahren zur herstellung von neuen, heterocyclisch substituierten 5-sulfamoyl- benzoesaeurederivaten und ihren salzen
US4118587A (en) * 1976-03-22 1978-10-03 Hoffmann-La Roche Inc. Novel 4-phenoxy-5-sulfamylbenzoic acid derivatives
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
DE2638716A1 (de) * 1976-08-27 1978-03-02 Ici Gmbh Antihypertensiva

Also Published As

Publication number Publication date
AU7252581A (en) 1982-01-07
US4564625A (en) 1986-01-14
ATE8627T1 (de) 1984-08-15
EP0043548B1 (de) 1984-07-25
CA1161449A (en) 1984-01-31
JPS5756426A (en) 1982-04-05
EP0043548A1 (de) 1982-01-13
AU538612B2 (en) 1984-08-23
DE3025367A1 (de) 1982-01-28
DE3165050D1 (en) 1984-08-30
ZA814523B (en) 1982-07-28

Similar Documents

Publication Publication Date Title
US4248856A (en) Sustained release pharmaceutical compositions
US20030083354A1 (en) Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions
EP2033633A2 (en) Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure
HU199302B (en) Process for producing synergic pharmaceutical compositions having hypotensive activity
HU186078B (en) Process for producing pharmaceutical compositions for peroral application containing dipyridamol
JPH0148245B2 (enExample)
US4952410A (en) Pharmaceutical products of moxonidine and hydrochlorothiazide
WO1998026765A1 (en) Stabilized pharmaceutical compositions and process for the preparation thereof
JPH0140009B2 (enExample)
CZ20001081A3 (en) Endothelin antagonist and beta-receptor blocker as compound preparations
WO2021181262A1 (en) Controlled release formulations comprising drotaverine or salt thereof
US5091191A (en) Pharmaceutical composition with improved dissolution property
EA002428B1 (ru) Стабильные композиции, содержащие левозимендан и альгиновую кислоту
US3932652A (en) Antidepressant compositions
SK278918B6 (sk) Farmaceutický prostriedok proti vysokému krvnému t
US4049791A (en) Prolonged acting appetite suppressant and anti-obesity compositions containing amphetamine adipate, dextroamphetamine adipate, amphetamine sulfate and dextroamphetamine sulfate as the active agents
US3993778A (en) Anti-ulcerogenic pharmaceutical compositions containing a 2-amino-3,5-dibromo-benzylamine and method of use
RU2145222C1 (ru) Фармацевтическая композиция, обладающая антигистаминным действием
KR960011773B1 (ko) 궤양의 예방 및 치료용 의약 조성물
US3904758A (en) Method of increasing wakefulness
CN101190890B (zh) 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺
RU2283649C1 (ru) Фармацевтическая композиция для лечения аллергических заболеваний
KR970006083B1 (ko) 위장질환 치료용 의약 조성물
US5182285A (en) Cell-protective composition for preventing or treating of peptic ulcer
RU2464018C1 (ru) Фармацевтическая композиция для лечения сердца пролонгированного действия